Clinical Trial Update: A Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating weekly carfilzomib in combination with dexamethasone for progressive multiple myeloma; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Carfilzomib (carfilzomib)
• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Amgen | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-08-09